Curcumin inhibits human lung large cell carcinoma cancer tumour growth in a murine xenograft model.

Chin-Cheng Su,Jai-Sing Yang,Chi-Cheng Lu,Jo-Hua Chiang,Chang-Lin Wu,Jen-Jyh Lin,Kuang-Chi Lai,Te-Chun Hsia,Hsu-Feng Lu,Ming-Jen Fan,Jing-Gung Chung
DOI: https://doi.org/10.1002/ptr.2905
IF: 6.388
2010-01-01
Phytotherapy Research
Abstract:Curcumin can decrease viable cells through the induction of apoptosis in human lung cancer NCI-H460 cells in vitro. However, there are no reports that curcumin can inhibit cancer cells in vivo. In this study, NCI-H460 lung tumour cells were implanted directly into nude mice and divided randomly into four groups to be treated with vehicle, curcumin (30 mg/kg of body weight), curcumin (45 mg/kg of body weight) and doxorubicin (8 mg/kg of body weight). Each agent was injected once ever), 4 days intraperitoneally (i.p.), with treatment starting 4 weeks after inoculation with the NCI-H460 cells. Treatment with 30 mg/kg an 45 mg/kg of curcumin or with 8 mg/kg of doxorubicin resulted in a reduction in tumour incidence, size and weight compared with the control group. The findings indicate that curcumin can inhibit tumour growth in a NCI-H460 xenograft animal model in vivo. Copyright (C) 2010 John Wiley & Sons, Ltd.
What problem does this paper attempt to address?